vimarsana.com
Home
Live Updates
Pharma Company Amarin Has a Key Asset and a Big Decision. Ho
Pharma Company Amarin Has a Key Asset and a Big Decision. Ho
Pharma Company Amarin Has a Key Asset and a Big Decision. How Sarissa Capital Can Help It Move Forward
Activist fund Sarissa brings extensive knowledge and deep contacts in the health-care space, which could come in handy at Amarin.
Related Keywords
United States ,
Ireland ,
Alex Denner ,
Medicines Company ,
Mochida Pharmaceutical Co ,
Ariad Pharmaceuticals Inc ,
Novartis ,
Pfizer ,
Supreme Court ,
European Union ,
Amarin Corporation Plc ,
Novartis International ,
Denner ,
Adventrx Pharmaceuticals ,
Mochida Pharmaceutical ,
Market Value ,
Sarissa Capital ,
Sarissa Capital Management ,
Takeda Pharmaceutical ,
Activist Spotlight ,
Amrn ,
Commentary ,
Hedge Funds ,
Investing ,
Investment Strategy ,
Stock Markets ,